Respiratory Medicine
Volume 103, Issue 7 , Pages 1056-1062 , July 2009

Interleukin-18 in induced sputum: Association with lung function in chronic obstructive pulmonary disease

  • Nikoletta Rovina

      Affiliations

    • Department of Respiratory Medicine, Medical School, University of Athens, “Sotiria” Hospital for Diseases of the Chest, 152 Mesogion Avenue, Athens GR-11527, Greece
    • Corresponding Author InformationCorresponding author. Tel.: +30 210 776 3314; fax: +30 210 723 9127.
    • ,
  • Efrossini Dima

      Affiliations

    • Department of Respiratory Medicine, Medical School, University of Athens, “Sotiria” Hospital for Diseases of the Chest, 152 Mesogion Avenue, Athens GR-11527, Greece
    • ,
  • Christina Gerassimou

      Affiliations

    • “M. Simos” Laboratories, Department of Critical Care and Pulmonary Services, Evangelismos Hospital, University of Athens, Athens, Greece
    • ,
  • Androniki Kollintza

      Affiliations

    • “M. Simos” Laboratories, Department of Critical Care and Pulmonary Services, Evangelismos Hospital, University of Athens, Athens, Greece
    • ,
  • Christina Gratziou

      Affiliations

    • Asthma and Allergy Centre, Pulmonary and Critical Care Department, Evgenidion Hospital, Medical School, University of Athens, Athens, Greece
    • ,
  • Charis Roussos

      Affiliations

    • Department of Respiratory Medicine, Medical School, University of Athens, “Sotiria” Hospital for Diseases of the Chest, 152 Mesogion Avenue, Athens GR-11527, Greece
    • “M. Simos” Laboratories, Department of Critical Care and Pulmonary Services, Evangelismos Hospital, University of Athens, Athens, Greece
    • Asthma and Allergy Centre, Pulmonary and Critical Care Department, Evgenidion Hospital, Medical School, University of Athens, Athens, Greece

Received 23 November 2008 ,Accepted 14 January 2009.

References 

  1. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256–1276
  2. Di Stefano A, Caramori G, Ricciardolo FLM. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview. Clin Exp Allergy. 2004;34:1156–1167
  3. McCourt M, Wang JH, Sookhai S, et al. Proinflammatory mediators stimulate neutrophil-directed angiogenesis. Arch Surg. 1999;134:1325–1332
  4. Hoshino T, Kato S, Oka N, et al. Pulmonary Inflammation and Emphysema: Role of the Cytokines IL-18 and IL-13. Am J Respir Crit Care Med. 2007;76:49–62
  5. Imaoka H, Hoshino T, Takei S, et al. IL-18 production and pulmonary function in chronic obstructive pulmonary disease. Eur Respir J. 2008;31(2):287–297
  6. Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukocyte Biol. 2003;73:213–224
  7. McInnes IB, Liew FY, Gracie JA. Interleukin-18: a therapeutic target in rheumatoid arthritis?. Arthritis Res Ther. 2005;7:38–41
  8. Reddy P. Interleukin-18: Recent advances. Curr Opin Hematol. 2004;11:405–410
  9. Dinarello CA. IL-18: a Th1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol. 1999;103:11–24
  10. Nakanishi K, Yoshimoto T, Tsutsui H, et al. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol. 2001;19:423–474
  11. Okamoto M, Kato S, Oizumi K, et al. Interleukin 18 (IL-18) in synergy with IL-2 induces lethal lung injury in mice: a potential role for cytokines, chemokines, and natural killer cells in the pathogenesis of interstitial pneumonia. Blood. 2002;99:1289–1298
  12. Kitasato Y, Hoshino T, Okamoto M, et al. Enhanced expression of interleukin-18 and its receptor in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 2004;31:619–625
  13. Kang MJ, Homer RJ, Gallo A, et al. IL-18 is induced and IL-18 receptor α plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation. J Immunol. 2007;178(3):1948–1959
  14. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease NHLBI/WHO Workshop report. Revised. ed. 2006 (Accessed November 25, 2006, at http://www.goldcopd.com).
  15. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report of Working Party on standardization of lung function tests, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J Suppl. 1993;16:5–40
  16. Rutgers SR, Timens W, Kaufmann HF, et al. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J. 2000;15:109–115
  17. Gracie JA, Forsey RJ, Chan WL, et al. A pro-inflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest. 1999;104:1393–1401
  18. D'Hulst AI, Maes T, Bracke , et al. Cigarette smoke-induced pulmonary emphysema in scid-mice. Is the acquired immune system required?. Respir Res. 2005;6:147
  19. Gebel S, Gebel S, Gerstmayer B, et al. The kinetics of transcriptomic changes induced by cigarette smoke in rat lungs reveals a specific program of defense, inflammation, and circadian clock gene expression. Toxicol Sci. 2006;93:422–431
  20. Hodge S, Hodge G, Scicchitano R, et al. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol. 2003;81:289–296
  21. Vlahos R, Bozinovski S, Hamilton JA, et al. Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF). Pharmacol Ther. 2006;112:106–115
  22. Schleimer RP. Innate immune responses and chronic obstructive pulmonary disease: “Terminator” or “Terminator 2”?. Proc Am Thorac Soc. 2005;2:342–346
  23. Kang MJ, Lee CG, Lee JY, et al. Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest. 2008;118(8):2771–2784
  24. Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state of the art review. Clin Microbiol Rev. 2001;14:336–363
  25. Soler N, Ewig S, Torres A, et al. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J. 1999;14:1015–1022
  26. Bandi V, Apicella MA, Mason E, et al. Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med. 2001;164:2114–2119
  27. Murphy TF, Brauer AL, Schiffmacher AT, et al. Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170:266–272
  28. Chin CL, Manzel LJ, Lehman EE, et al. Haemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers. Am J Respir Crit Care Med. 2005;172:85–91
  29. McKay A, Komai-Koma M, MacLeod KJ, et al. Interleukin-18 levels in induced sputum are reduced in asthmatic and normal smokers. Clin Exp Allergy. 2004;34:904–910
  30. Saetta M, Turato G, Maestrelli P, et al. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:1304–1309
  31. Willemse BW, ten Hacken NH, Rutgers B, et al. Association of current smoking with airway inflammation in chronic obstructive pulmonary disease and asymptomatic smokers. Respir Res. 2005;6:38
  32. Thompson AB, Daughton D, Robbins RA, et al. Intraluminar airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am Rev Respir Dis. 1989;140:1527–1537
  33. Turato G, Di Stefano A, Maestrelli P, et al. Effect of smoking cessation on airway inflammation in chronic bronchitis. Am J Respir Crit Care Med. 1995;152:1262–1267
  34. Linden M, Rasmussen JB, Piitulainen E, et al. Airway inflammation in smokers with non obstructive and obstructive chronic bronchitis. Am Rev Respir Dis. 1993;148:1226–1232
  35. Rovina N, Papapetropoulos A, Kollintza A, et al. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?. Respir Res. 2007;8:53
  36. Burge PS, Calverley PM, Jones PW, et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ. 2000;320:1297–1303
  37. Pauwels RA, Lofdahl CG, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med. 1999;340:1948–1953

PII: S0954-6111(09)00027-4

doi: 10.1016/j.rmed.2009.01.011

Respiratory Medicine
Volume 103, Issue 7 , Pages 1056-1062 , July 2009

Article Tools

* Image Usage & Resolution